554 related articles for article (PubMed ID: 15748903)
21. Hormone-induced nucleosome positioning in the MMTV promoter is reversible.
Belikov S; Gelius B; Wrange O
EMBO J; 2001 Jun; 20(11):2802-11. PubMed ID: 11387213
[TBL] [Abstract][Full Text] [Related]
22. HNF-3beta is a critical factor for the expression of the Jaagsiekte sheep retrovirus long terminal repeat in type II pneumocytes but not in Clara cells.
McGee-Estrada K; Palmarini M; Fan H
Virology; 2002 Jan; 292(1):87-97. PubMed ID: 11878911
[TBL] [Abstract][Full Text] [Related]
23. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo.
Truss M; Bartsch J; Schelbert A; Haché RJ; Beato M
EMBO J; 1995 Apr; 14(8):1737-51. PubMed ID: 7737125
[TBL] [Abstract][Full Text] [Related]
24. Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo.
Belikov S; Astrand C; Holmqvist PH; Wrange O
Mol Cell Biol; 2004 Apr; 24(7):3036-47. PubMed ID: 15024090
[TBL] [Abstract][Full Text] [Related]
25. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
[TBL] [Abstract][Full Text] [Related]
26. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans.
Sharma SK; Leinemann U; Ratke R; Oetjen E; Blume R; Dickel C; Knepel W
Biochem J; 2005 Aug; 389(Pt 3):831-41. PubMed ID: 15828872
[TBL] [Abstract][Full Text] [Related]
29. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.
Aurrekoetxea-Hernández K; Buetti E
J Virol; 2000 Jun; 74(11):4988-98. PubMed ID: 10799572
[TBL] [Abstract][Full Text] [Related]
30. [Transcription factors of the nuclear factor 1 (NF1) family. Role in chromatin remodelation].
Chikhirzhina GI; Al'-Shekhadat RI; Chikhirzhina EV
Mol Biol (Mosk); 2008; 42(3):388-404. PubMed ID: 18702298
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid receptor-mediated chromatin remodeling in vivo.
Deroo BJ; Archer TK
Oncogene; 2001 May; 20(24):3039-46. PubMed ID: 11420719
[TBL] [Abstract][Full Text] [Related]
32. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure.
Astrand C; Klenka T; Wrange O; Belikov S
Eur J Biochem; 2004 Mar; 271(6):1153-62. PubMed ID: 15009194
[TBL] [Abstract][Full Text] [Related]
33. Chromatin structure modulates transcription factor binding to the mouse mammary tumor virus (MMTV) promoter.
Truss M; Bartsch J; Hache RS; Beato M
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):1-10. PubMed ID: 8274422
[TBL] [Abstract][Full Text] [Related]
34. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
Zhu Q; Dudley JP
J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
[TBL] [Abstract][Full Text] [Related]
35. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
36. Assembly of glucocorticoid receptor and c-JUN homodimer on the promoter of mouse mammary tumor virus-long terminal repeat is influenced by order of addition.
Hsu TC; Melchiorre LP; Maksymowych AB; Kmiec E; Litwack G
Biochem Biophys Res Commun; 1993 Dec; 197(3):1260-6. PubMed ID: 8280142
[TBL] [Abstract][Full Text] [Related]
37. Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat.
Kusk P; Carlson KE; Warren BS; Hager GL
Mol Endocrinol; 1995 Sep; 9(9):1180-92. PubMed ID: 7491110
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
39. The initiation of liver development is dependent on Foxa transcription factors.
Lee CS; Friedman JR; Fulmer JT; Kaestner KH
Nature; 2005 Jun; 435(7044):944-7. PubMed ID: 15959514
[TBL] [Abstract][Full Text] [Related]
40. Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling.
Sreenath K; Pavithra L; Singh S; Sinha S; Dash PK; Siddappa NB; Ranga U; Mitra D; Chattopadhyay S
Virology; 2010 Apr; 400(1):76-85. PubMed ID: 20153010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
